ArticleBreast cancer research and treatment2023

Effect of prior treatments on post-CDK 4/6 inhibitor survival in hormone receptor-positive breast cancer.

Jeffrey Franks et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.